MyAverix Finance
BR · Healthcare
Fagron NV (FAGR)
Drug Manufacturers - Specialty & Generic
Fagron NV (FAGR) is listed on BR in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported market cap is $1.83B, P/E ratio is 20.16, net margin is 9.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for FAGR
Fagron NV (FAGR) — FAQ
What is Fagron NV's market cap?
Fagron NV (FAGR) has a reported market cap of $1.83B (data as of 2026-05-24).
What is FAGR's P/E ratio?
The price-to-earnings (P/E) ratio for Fagron NV (FAGR) is 20.16 (data as of 2026-05-24).
Does Fagron NV pay a dividend?
Dividend yield is not available in the current snapshot for Fagron NV (FAGR). Check the MyAverix Finance app for the latest dividend data.
What sector is Fagron NV in?
Fagron NV (FAGR) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is FAGR listed on?
FAGR is listed on BR.
What is Fagron NV's net margin?
Fagron NV (FAGR) reports a net margin of 9.6% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.